You are here

Bioiberica successfully passed an unannounced inspection by the FDA

28 May 2013

Last May Bioiberica had a non scheduled inspection from the US FDA in its facility in Geneva (Nebraska) where the first steps of heparin sodium production are performed.

Bioiberica is pleased to announce that this three days inspection finished with no deviations.
Once again, Bioiberica was able to demonstrate its extremely high quality level, a key factor to keep its worldwide leading position as heparin sodium manufacturer.